Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Mar;60(3):412-8.
doi: 10.1016/j.jaad.2008.10.023.

The role of case reports in evidence-based practice, with suggestions for improving their reporting

Joerg Albrecht  1 , Victoria P Werth, Michael Bigby
Affiliations

The role of case reports in evidence-based practice, with suggestions for improving their reporting

Joerg Albrecht et al. J Am Acad Dermatol. 2009 Mar.

Abstract

Background: Case reports are part of the evidence hierarchy in evidence-based practice and guide an important part of dermatologic practice.

Objective: This article discusses the role of case reports and series in evidence-based practice and suggests how to improve reporting.

Methods: This article was inspired by a forum on the role of case reporting in dermatologic practice presented at a meeting of the American Academy of Dermatology. It is based on an informal literature review and the authors' experience in systematically reviewing case reports in medicine and dermatology.

Results: Case reports significantly influence medicine. Often they are the first line of evidence for new therapies but rarely are sufficient to establish treatment efficacy. Frequently they are the first and sometimes major source for detecting rare adverse events. Guidelines for improving the reporting of case reports and series are discussed.

Limitations: This paper represents the views of the authors and is neither a systematic review of the literature nor a formal consensus document.

Conclusion: Case reports are an important part of medical literature and need to be taken seriously.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None declared.

Figures

Fig 1
Fig 1
Myasthenia gravis treated with physostigmine by Walker. Reprinted from The Lancet, with permission from Elsevier.
Fig 2
Fig 2
Evidence pyramid. Adapted with permission from State University of New York Downstate Medical Center Medical Research Library of Brooklyn, New York. Available at: http://library.downstate.edu/ebmdos/2100.htm. Accessed March 7, 2008.
See this image and copyright information in PMC

References

    1. Walker MB. Treatment of myasthenia gravis with physostigmine. Lancet. 1934;1:1200–1.
    1. Moses LE. The series of consecutive cases as a device for assessing outcomes of intervention. N Engl J Med. 1984;311:705–10. - PubMed
    1. Oxford Center for Evidence-based Medicine. [Accessed March 9, 2006.];Levels of evidence. 2001 Available from: URL: http://www.cebm.net/levels_of_evidence.asp.
    1. Stephens MDB. Introduction. In: Stephens MDB, Talbot JCC, Routledge PA, editors. Detection of new adverse drug reactions. London: Macmillan Reference Ltd; 1998. pp. 1–57.
    1. Albrecht J, Meves A, Bigby M. Case reports and case series from Lancet had significant impact on medical literature. J Clin Epidemiol. 2005;58:1227–32. - PubMed

Publication types